Sponsor Pipeline

Hangzhou Gensciences Biopharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
3
Recruiting
4
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06142552 Phase 3 Clinical Project of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion… Severe Hemophilia A Recruiting
NCT07663903 Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) On-Demand… Severe Hemophilia A Recruiting
NCT07684898 Study of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW107) as… Severe Hemophilia A Recruiting
NCT06136507 Study of Efficacy and Safety of FRSW107 in Pediatric Patients With Severe Hemophilia A Severe Hemophilia A Not Yet Recruiting
Disease Areas
Hemophilia (4)
Get alerts when Hangzhou Gensciences Biopharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free